Ropes & Gray Advises the Underwriters on Relay Therapeutics’ $200 Million Follow-on Offering

In The News
September 11, 2024

Ropes & Gray represented the underwriters on Relay Therapeutics’ follow-on public offering of $200 million in shares of common stock. The offering priced on Sept. 10.

Relay Therapeutics is a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies with the goal of bringing life-changing therapies to patients. 

The team was led by capital markets partner Will Michener.